Jacobsen Donald W, Catanescu Otilia, Dibello Patricia M, Barbato John C
Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Clin Chem Lab Med. 2005;43(10):1076-83. doi: 10.1515/CCLM.2005.188.
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Although there is a growing body of evidence that homocysteine plays a causal role in atherogenesis, specific mechanisms to explain the underlying pathology have remained elusive. This review focuses on chemistry unique to the homocysteine molecule to explain its inherent cytotoxicity. Thus, the high pKa of the sulfhydryl group (pKa=10.0) of homocysteine underlies its ability to form stable disulfide bonds with protein cysteine residues, and in the process, alters or impairs the function of the protein. Albumin, fibronectin, transthyretin, annexin II, and factor V have now been identified as molecular targets for homocysteine, and in the case of albumin, the mechanism of targeting has been elucidated.
高同型半胱氨酸血症是心血管疾病的一个独立危险因素。尽管越来越多的证据表明同型半胱氨酸在动脉粥样硬化形成中起因果作用,但解释潜在病理的具体机制仍不清楚。本综述聚焦于同型半胱氨酸分子特有的化学性质,以解释其固有的细胞毒性。因此,同型半胱氨酸巯基的高pKa值(pKa = 10.0)是其与蛋白质半胱氨酸残基形成稳定二硫键的能力的基础,在此过程中会改变或损害蛋白质的功能。白蛋白、纤连蛋白、转甲状腺素蛋白、膜联蛋白II和因子V现已被确定为同型半胱氨酸的分子靶点,就白蛋白而言,其靶向机制已得到阐明。